Literature DB >> 17359502

Kidney transplant rejection in Australia and New Zealand: relationships between rejection and graft outcome.

S McDonald1, G Russ, S Campbell, S Chadban.   

Abstract

Although acute rejection rates have fallen over time, how this relates to graft outcomes is not known. Using data from the ANZDATA Registry, we examined associations of rejection within six months of transplantation with graft and patient outcomes among kidney-only transplants performed between April 1997 and December 2004 in Australia and New Zealand. Associations of biopsy histology with outcomes of the rejection episode were also examined. Outcomes were examined among 4325 grafts with 1961 rejection episodes in total. Crude rejection rates have fallen by one-third over that time, but rates of graft survival are constant. The occurrence of acute rejection was associated with an increased risk of graft loss after 6 months (HR, adjusted for donor and recipient characteristics, 1.69 [1.36-2.11], p<0.001). Late rejection (first rejection >or=90 days) was associated with higher risk of graft loss (adjusted HR 2.46 [1.70-3.56], p<0.001). Vascular rejection was also associated with a higher risk of graft loss 2.07 [95% CI 1.60-2.68], p<0.001. The occurrence of acute rejection is associated with an ongoing increased risk of graft loss, particularly if that episode occurred late or included vascular rejection. The reduced rates of rejection have not been associated with improved graft survival.

Entities:  

Mesh:

Year:  2007        PMID: 17359502     DOI: 10.1111/j.1600-6143.2007.01759.x

Source DB:  PubMed          Journal:  Am J Transplant        ISSN: 1600-6135            Impact factor:   8.086


  16 in total

1.  Absence of MyD88 signaling induces donor-specific kidney allograft tolerance.

Authors:  Huiling Wu; Gerda A Noordmans; Maya R O'Brien; Jin Ma; Cathy Y Zhao; Geoff Y Zhang; Tony K T Kwan; Stephen I Alexander; Steven J Chadban
Journal:  J Am Soc Nephrol       Date:  2012-08-09       Impact factor: 10.121

2.  Influence of combined treatment of low dose rapamycin and cyclosporin A on corneal allograft survival.

Authors:  Svetlana Stanojlovic; Stephan Schlickeiser; Christine Appelt; Katrin Vogt; Isabela Schmitt-Knosalla; Stefanie Haase; Thomas Ritter; Birgit Sawitzki; Uwe Pleyer
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2010-06-24       Impact factor: 3.117

3.  Behavioral measures to reduce non-adherence in renal transplant recipients: a prospective randomized controlled trial.

Authors:  Márcia Fátima Faraldo Martinez Garcia; Ariane Moyses Bravin; Paula Dalsoglio Garcia; Mariana Moraes Contti; Hong Si Nga; Henrique Mochida Takase; Luis Gustavo Modelli de Andrade
Journal:  Int Urol Nephrol       Date:  2015-09-16       Impact factor: 2.370

4.  Long-Term Outcomes after Acute Rejection in Kidney Transplant Recipients: An ANZDATA Analysis.

Authors:  Philip A Clayton; Stephen P McDonald; Graeme R Russ; Steven J Chadban
Journal:  J Am Soc Nephrol       Date:  2019-07-15       Impact factor: 10.121

5.  Spontaneous resolution of acute T cell-mediated rejection in a renal transplant patient.

Authors:  Y M Hong; S H Kim; H C Yu; B H Cho; S J Noh; M J Kang; S K Park; S Lee
Journal:  Int Urol Nephrol       Date:  2012-01-06       Impact factor: 2.370

6.  Everolimus with Reduced Calcineurin Inhibitor Exposure in Renal Transplantation.

Authors:  Julio Pascual; Stefan P Berger; Oliver Witzke; Helio Tedesco; Shamkant Mulgaonkar; Yasir Qazi; Steven Chadban; Federico Oppenheimer; Claudia Sommerer; Rainer Oberbauer; Yoshihiko Watarai; Christophe Legendre; Franco Citterio; Mitchell Henry; Titte R Srinivas; Wen-Lin Luo; AnaMaria Marti; Peter Bernhardt; Flavio Vincenti
Journal:  J Am Soc Nephrol       Date:  2018-05-11       Impact factor: 10.121

7.  Managing bronchiolitis obliterans syndrome (BOS) and chronic lung allograft dysfunction (CLAD) in children: what does the future hold?

Authors:  Gregory I Snell; Miranda Paraskeva; Glen P Westall
Journal:  Paediatr Drugs       Date:  2013-08       Impact factor: 3.022

Review 8.  The pathogenesis and treatment of chronic allograft nephropathy.

Authors:  Can Li; Chul Woo Yang
Journal:  Nat Rev Nephrol       Date:  2009-07-28       Impact factor: 28.314

9.  Demethylation of the TSDR is a marker of squamous cell carcinoma in transplant recipients.

Authors:  S N Sherston; K Vogt; S Schlickeiser; B Sawitzki; P N Harden; K J Wood
Journal:  Am J Transplant       Date:  2014-09-23       Impact factor: 8.086

10.  Does reduction in mycophenolic acid dose compromise efficacy regardless of tacrolimus exposure level? An analysis of prospective data from the Mycophenolic Renal Transplant (MORE) Registry.

Authors:  Anthony Langone; Cataldo Doria; Stuart Greenstein; Mohanram Narayanan; Kimi Ueda; Bashir Sankari; Oleh Pankewycz; Fuad Shihab; Laurence Chan
Journal:  Clin Transplant       Date:  2012-08-02       Impact factor: 2.863

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.